• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Healthcare Regulatory Update: The United Arab Emirates
 

Healthcare Regulatory Update: The United Arab Emirates

on

  • 243 views

IntroductionThe fragmented nature of the healthcare systems in the United Arab Emirates remains despite the implementation of health reforms in the emirates of Abu Dhabi and Dubai. The two major ...

IntroductionThe fragmented nature of the healthcare systems in the United Arab Emirates remains despite the implementation of health reforms in the emirates of Abu Dhabi and Dubai. The two major emirates are currently at different stages in the development and implementation of reform with the gap between them in terms of access to healthcare and pharmaceuticals widening, with Abu Dhabi leading the way.Scope*Insight into the inequality of healthcare access and associated costs which has led to reform in the UAE*Overview of the latest regulatory reforms in the UAE and their impact on key stakeholders*Update of strategies to improve healthcare standards and access in Abu Dhabi*Update of strategies to improve healthcare standards and access in DubaiHighlightsHealthcare reforms in the UAE have aimed to improve the accessibility and quality of healthcare services available to residents while reducing the burden of public financing of healthcare. Since 2009, a number of reforms have been proposed and implemented, while others have been postponed in light of the recent global economic downturn.In Abu Dhabi, since the passing of the Health Insurance Bill in 2005, most residents are now covered by health insurance, with this being justified by increasing encounters between physicians and patients. The HAAD has also implemented a number of cost saving strategies, a screening program for nationals, and an eHealth platform.In Dubai, the timelines for the proposed health insurance reforms have been postponed. For expatriates, especially those on very low wages (such as labourers), the postponement will mean that access to healthcare will remain patchy, since they will have to pay out-of-pocket for treatment, or depend on the goodwill of their employers.Reasons to Purchase*Understand the latest changes to the UAE healthcare market and the strategic implications of current/ future reforms to your business*Identify opportunities for mutually beneficial relationships between your firm and other stakeholders*Understand the latest commercial trends adopted in the healthcare industry in response to, and in anticipation of the latest reforms

Statistics

Views

Total Views
243
Views on SlideShare
243
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Healthcare Regulatory Update: The United Arab Emirates Healthcare Regulatory Update: The United Arab Emirates Document Transcript

    • Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Healthcare Regulatory Update: The United Arab EmiratesPublished on January 2010 Report SummaryIntroductionThe fragmented nature of the healthcare systems in the United Arab Emirates remains despite the implementation of health reformsin the emirates of Abu Dhabi and Dubai. The two major emirates are currently at different stages in the development andimplementation of reform with the gap between them in terms of access to healthcare and pharmaceuticals widening, with Abu Dhabileading the way.Scope*Insight into the inequality of healthcare access and associated costs which has led to reform in the UAE*Overview of the latest regulatory reforms in the UAE and their impact on key stakeholders*Update of strategies to improve healthcare standards and access in Abu Dhabi*Update of strategies to improve healthcare standards and access in DubaiHighlightsHealthcare reforms in the UAE have aimed to improve the accessibility and quality of healthcare services available to residents whilereducing the burden of public financing of healthcare. Since 2009, a number of reforms have been proposed and implemented, whileothers have been postponed in light of the recent global economic downturn.In Abu Dhabi, since the passing of the Health Insurance Bill in 2005, most residents are now covered by health insurance, with thisbeing justified by increasing encounters between physicians and patients. The HAAD has also implemented a number of cost savingstrategies, a screening program for nationals, and an eHealth platform.In Dubai, the timelines for the proposed health insurance reforms have been postponed. For expatriates, especially those on very lowwages (such as labourers), the postponement will mean that access to healthcare will remain patchy, since they will have to payout-of-pocket for treatment, or depend on the goodwill of their employers.Reasons to Purchase*Understand the latest changes to the UAE healthcare market and the strategic implications of current/ future reforms to yourbusiness*Identify opportunities for mutually beneficial relationships between your firm and other stakeholders*Understand the latest commercial trends adopted in the healthcare industry in response to, and in anticipation of the latest reformsHealthcare Regulatory Update: The United Arab Emirates Page 1/5
    • Find Industry reports, Company profilesReportLinker and Market Statistics Table of ContentABOUT DATAMONITOR HEALTHCARE 2About the Strategic Pharmaceutical Analysis Team 21. Executive Summary 3Strategic scoping and focus 3Key findings 3Related reports 4Table of Contents 52. Overview of regulatory and commercial trends in the UAE 6Key findings 6Inequality of healthcare access and associated costs has led to reform in the UAE 7High price of drugs in the UAE has contributed to high healthcare costs and inequality to access 7The WHO medicine price survey confirms the high drug prices and the limited availability of generics in the UAE 8General Sale List (GSL) items have seen rapid price increases between 2008 and 2009 impacting access to low-cost medicines 8Reluctance of the MOH to approve branded drugs manufactured in neighboring countries limits cost saving potential 9Generic manufacturers diversify along the value chain 10Local generics manufacturers are transitioning towards innovative manufacturing 10Local generics manufacturers have also been moving into distribution and retail 10Overview of healthcare reforms in Abu Dhabi and Dubai 123. Regulatory update of healthcare reforms in Abu Dhabi 13Key findings 13Update of strategies to improve healthcare standards and access in Abu Dhabi 14HAADs proposed pro-generic regulatory interventions 15Development of a positive formulary list for the basic health insurance policy 16Diagnosis coding is expected to lead to the reduction of medical errors 16Rational drug use program cuts down unnecessary prescribing 16Compulsory prescription by molecular name 17The HAAD has developed a number of strategies to limit future drug shortages 20The Ministry of Health has fast-tracked approval for the manufacturing of vaccines locally for emergency use 21The HAAD is expanding the Weqaya screening program to include follow up tests and mammograms 23Implications of the introduction of the Thiqa program 26Introduction of co-payments to the Thiqa program to prevent abuse 27Standardization of healthcare pathways 28Improving patient compliance 29DAMAN to block reimbursement for inferior medical treatment 314. Regulatory update of healthcare reforms in Dubai 32Key findings 32Update of strategies to improve healthcare standards and access in Dubai 33Expatriate private sector insurance reforms delayed, but public sector reforms enacted 34The timelines for the implementation of the health insurance reforms in Dubai have been postponed 35Sanofi-Aventis capitalizes on inequality in healthcare access in the UAE 36Implementation of health insurance program for public sector employees 36Launch of small-scale screening programs in Dubai 375. Bibliography 39Contributing experts 39Healthcare Regulatory Update: The United Arab Emirates Page 2/5
    • Find Industry reports, Company profilesReportLinker and Market StatisticsDatamonitor reports 39Publications and online articles 39APPENDIX 42Exchange rates 42About Datamonitor 43About Datamonitor Healthcare 43Datamonitor consulting 43Disclaimer 44List of TablesTable 1: Trends in public and private sector healthcare facilities, Abu Dhabi, 2007-08 26Table 2: Summary of the Enaya insurance plan in Dubai 37Table 3: Exchange rates, 2009 42List of FiguresFigure 1: The Health Authority of Abu Dhabis (HAAD) Unified Prescription Form 18Figure 2: Impact of the HAADs pro-generic reforms in February 2009 on consumption of brands in March 2009 in Abu Dhabi 19Figure 3: Flow-chart showing reasons for drug unavailability in Abu Dhabi, 2009 20Figure 4: The roll-out (Phase 1) and subsequent development of the Weqaya program in Abu Dhabi, 2008-09 23Figure 5: The Health Authority of Abu Dhabis (HAAD) Public Health Priority Matrix for Abu Dhabi, 2010 25Figure 6: Access to healthcare for nationals and expatriates at public and private healthcare facilities in Dubai, 2009 35Healthcare Regulatory Update: The United Arab Emirates Page 3/5
    • Find Industry reports, Company profilesReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Healthcare Regulatory Update: The United Arab Emirates Product Formats Please select the product formats and the quantity you require. Digital Copy--USD 3 800.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Healthcare Regulatory Update: The United Arab Emirates Page 4/5
    • Find Industry reports, Company profilesReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Healthcare Regulatory Update: The United Arab Emirates Page 5/5